Adipocyte volumes and levels of adipokines in diabetes and obesity

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 4, 2008, Pages 253-258

  Gokalp, Deniz ^a   Bahceci, Mithat ^a   Ozmen, Sehmus ^a   Arikan, Senay ^a   Tuzcu, Alpaslan ^a   Danis, Ramazan ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Adipocyte volume; Adiponectin; Diabetes; Obesity; Resistin

Indexed keywords

ADIPOCYTOKINE; LIPID; RESISTIN;

ADIPOCYTE; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; DISEASE COURSE; ELECTIVE SURGERY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LABORATORY TEST; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SUBCUTANEOUS FAT;

EID: 55549117782     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2008.07.001     Document Type: Article

References (38)

1. Zimmet P., and Thomas C.R. Genotype, obesity and cardiovascular disease-has technical and social advancement outstripped evolution?. J Int Med 254 (2003) 114-125
2. Rashid M.N., Fuentes F., Touchon R.C., and Wehner P.S. Obesity and the risk for cardiovascular disease. Prev Cardiol 6 (2003) 42-47
3. Cummings D.E., and Schwartz M.W. Genetics and pathophysiology of human obesity. Annu Rev Med 54 (2003) 453-471
4. Schwartz M.W. Brain pathways controlling food intake and body weight. Exp Biol Med 226 (2001) 978-981
5. Bloomgarden Z.T. Adiposity and diabetes. Diabetes Care 25 (2002) 2342-2349
6. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
7. Arner P. Insulin resistance in type 2 diabetes-role of the adipokines. Curr Mol Med 5 (2005) 333-339
8. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 (2005) 911-919
9. Shand B.I., Scott R.S., Elder P.A., and George P.M. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 5 (2003) 349-353
10. Tschritter O., Fritsche A., Thamer C., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52 (2003) 239-243
11. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
12. Kadowaki T., Hara K., Yamauchi T., Terauchi Y., Tobe K., and Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Biol Med 228 (2003) 1111-1117
13. Steppan C.M., Brown E.J., Wright C.M., et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98 (2001) 502-506
14. McTernan P.G., McTernan C.L., Chetty R., et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87 (2002) 2407
15. Silha J.V., Krsek M., Skrha J.V., Sucharda P., Nyomba B.L., and Murphy L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149 (2003) 331-335
16. Azuma K., Katsukawa F., Oguchi S., et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11 (2003) 997-1001
17. Bjorntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med 24 (1992) 15-18
18. Chan D.C., Watts G.F., Sussekov A.V., et al. Adipose tissue compartments and insulin resistance in overweight-obese Caucasian men. Diabetes Res Clin Pract 63 (2004) 77-85
19. Ross R., Aru J., Freeman J., Hudson R., and Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282 (2002) E657-E663
20. Misra A., Garg A., Abate N., Peshock R.M., Stray-Gundersen J., and Grundy S.M. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 5 (1997) 93-99
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., and Treacher D.F. Turner RC homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Goldrick R.B. Morphological changes in the adipocyte during fat deposition and mobilization. Am J Physiol 212 (1967) 777-782
23. Björntorp P., and Karlsson K. Triglyceride synthesis in human subcutaneous adipose tissue cells of different size. Eur J Clin Invest 1 (1970) 112-117
24. Björntorp P., and Sjöström L. The composition and metabolism in vitro of adipose tissue fat cells of different sizes. Eur J Clin Invest 2 (1972) 78-84
25. Smith U. Effect of cell size on lipid synthesis by human adipose tissue in vitro. J Lipid Res 12 (1971) 65-69
26. Smith U. Studies of human adipose tissue in culture, I. Incorporation of glucose and release of glycerol. Anat Rec 172 (1971) 597-602
27. Salans L.B., Knittle J.L., and Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest 47 (1968) 153-165
28. Salans L.B., and Dougherty J.W. The effect of insulin upon glucose metabolism by adipose cells of different size. J Clin Invest 50 (1971) 1399-1410
29. Van Harmelen V., Reynisdottir S., Eriksson P., et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47 (1998) 913-917
30. Coppack S.W. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60 (2001) 349-356
31. Weyer C., Foley J.E., Bogardus C., Tataranni P.A., and Pratley R.E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43 (2000) 1498-1506
32. Adams M., Montague C.T., Prins J.B., et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100 (1997) 3149-3153
33. Lam T.K., van de Werve G., and Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 284 2 (2003) E281-E290
34. Lewis G.F., Carpentier A., Adeli K., and Giacca A. Disordered fat storage and mobilization in the pathogenesis of Insulin resistance and type 2 diabetes. Endocrin Rev 23 2 (2002) 201-229
35. Holcomb I.N., Kabakoff R.C., Chan B., Baker T.W., Gurney A., Henzel W., et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19 (2000) 4046-4055
36. Kim M.-J., Yoo K.-H., Park H.-S., Chung S.-M., Jin C.-J., lee Y., et al. Plasma adiponektin and insulin resistance in Korean type 2 diabetes mellitus. Yonsei Med J 46 1 (2005) 42-50
37. Nedvidkova J., Smitka K., Kopsky V., and Hainer V. Adiponectin, an adipocyte-derived protein. Physiol Res 54 2 (2005) 133-140
38. Berk E.S., Kovera A.J., Boozer C.N., Pi-Sunyer F.X., Johnson J.A., and Albu J.B. Adiponectin levels during low- and high-fat eucaloric diets in lean and obese women. Obes Res 13 9 (Sep. 2005) 1566-1571